Skip to main content
main-content

Zeitschrift

Diabetes Therapy

Research, treatment and education of diabetes and related disorders

Diabetes Therapy OnlineFirst articles

20.11.2018 | Case Report Open Access

A Case of Fulminant Type 1 Diabetes with Gastric and Urinary Retention

Fulminant type 1 diabetes (fT1D) is a severe subtype of type 1 diabetes which progresses rapidly with islet cells destroyed almost completely within a short period of time. It is often characterized by flu-like or gastrointestinal symptoms at the …

19.11.2018 | Original Research Open Access

Unmet Needs in the Management of Type 2 Diabetes Mellitus Patients Starting Insulin Therapy with Basal or Premix Insulin in Routine Clinical Practice in Serbia

Type 2 diabetes mellitus (T2DM) is a progressive disease with declining beta cell function, ultimately necessitating introduction of insulin therapy. Despite well-documented benefits of timely glycemic control and consensus guidelines encouraging …

19.11.2018 | Original Research Open Access

Ticagrelor Versus Prasugrel for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Antiplatelet therapy is very important following percutaneous coronary intervention (PCI) to reduce the risk of post-interventional complications. However, bleeding risk might be a limiting factor of these blood thinners [ 1 ]. New generation P2Y …

15.11.2018 | Case Series Open Access

Successful Outcomes with Insulin Degludec in Pregnancy: A Case Series

Optimal glycaemic control pre-conception and throughout pregnancy is paramount to achieve the best outcomes and to minimise the risk of complications for the mother and baby. Current long-acting insulin analogues that have been approved by the …

14.11.2018 | Original Research Open Access

Incidence of Diabetes in the Working Population in Spain: Results from the ICARIA Cohort

Diabetes mellitus carries a tremendous healthcare burden. In 2017, the disease had a worldwide prevalence in adults of 8.8% and was associated with 4.0 million deaths and health expenditure of USD 727 billion [ 1 ]. The development of type 2 …

Aktuelle Ausgaben

Über diese Zeitschrift

Diabetes Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of diabetes therapies. Studies relating to diagnosis, devices and diabetes technology, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world.

Moving forward from traditional publishing, Diabetes Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

Diabetes Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

Upon acceptance of your article for publication, you will be required to pay the article processing charge of £230/$360 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access.

For more information about the journal, please contact hayley.wood@springer.com or see the News page for the latest journal offers.

Weitere Informationen

Neu im Fachgebiet Innere Medizin

Meistgelesene Bücher aus der Inneren Medizin

2017 | Buch

Rheumatologie aus der Praxis

Entzündliche Gelenkerkrankungen – mit Fallbeispielen

Dieses Fachbuch macht mit den wichtigsten chronisch entzündlichen Gelenk- und Wirbelsäulenerkrankungen vertraut. Anhand von über 40 instruktiven Fallbeispielen werden anschaulich diagnostisches Vorgehen, therapeutisches Ansprechen und der Verlauf …

Herausgeber:
Rudolf Puchner

2016 | Buch

Ambulant erworbene Pneumonie

Was, wann, warum – Dieses Buch bietet differenzierte Diagnostik und Therapie der ambulant erworbenen Pneumonie zur sofortigen sicheren Anwendung. Entsprechend der neuesten Studien und Leitlinien aller wichtigen Fachgesellschaften.

Herausgeber:
Santiago Ewig

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise